Benzinga's Top #PreMarket Gainers
September 08, 2015 at 08:15 AM EDT
Immunomedics, Inc. (NASDAQ: IMMU) shares rose 29.77 percent to $2.79 in pre-market trading following announcement of interim Phase 2 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.